BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8948379)

  • 1. Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand.
    Gaywee J; Artenstein AW; VanCott TC; Trichavaroj R; Sukchamnong A; Amlee P; de Souza M; McCutchan FE; Carr JK; Markowitz LE; Michael R; Nittayaphan S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(4):392-6. PubMed ID: 8948379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand.
    Pau CP; Lee-Thomas S; Auwanit W; George JR; Ou CY; Parekh BS; Granade TC; Holloman DL; Phillips S; Schochetman G
    AIDS; 1993 Mar; 7(3):337-40. PubMed ID: 8471195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing.
    Nkengasong JN; Willems B; Janssens W; Cheingsong-Popov R; Heyndrickx L; Barin F; Ondoa P; Fransen K; Goudsmit J; van der Groen G
    AIDS; 1998 Aug; 12(12):1405-12. PubMed ID: 9727560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
    Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
    Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 subtyping using gag/env heteroduplex mobility assay and peptide enzyme-linked immunosorbent assay.
    Simparak W; Kositanont U; Sutthent R; Wasinrapee P; Chaowanachan T; Wasi C
    Asian Pac J Allergy Immunol; 2005; 23(2-3):143-52. PubMed ID: 16252845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic and genetic characterization of HIV type 1 subtypes on Reunion Island.
    Brengel-Pesce K; Innocenti-Francillard P; Morand P; Michault A; Poubeau P; Barin F; Saragosti S; Seigneurin JM
    AIDS Res Hum Retroviruses; 1999 Jun; 15(9):787-92. PubMed ID: 10381166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies.
    Polonis VR; De Souza MS; Chanbancherd P; Chantakulkij S; Jugsudee A; Loomis-Price LD; Vancott TC; Garner R; Markowitz LE; Brown AE; Birx DL
    AIDS Res Hum Retroviruses; 2001 Jan; 17(1):69-79. PubMed ID: 11177385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of HIV-1 subtypes in Fukuoka, Japan.
    Chijiwa K; Ishibashi T; Kashiwagi S; Mori R
    Microbiol Immunol; 1999; 43(3):271-8. PubMed ID: 10338197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania.
    Lukashov VV; Cornelissen MT; Goudsmit J; Papuashvilli MN; Rytik PG; Khaitov RM; Karamov EV; de Wolf F
    AIDS; 1995 May; 9(5):435-9. PubMed ID: 7639968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization.
    Cheingsong-Popov R; Lister S; Callow D; Kaleebu P; Beddows S; Weber J
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1379-86. PubMed ID: 7888191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity.
    Subbarao S; Limpakarnjanarat K; Mastro TD; Bhumisawasdi J; Warachit P; Jayavasu C; Young NL; Luo CC; Shaffer N; Kalish ML; Schochetman G
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):319-27. PubMed ID: 9519893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid grouping of HIV-1 infection in subtypes A to E by V3 peptide serotyping and its relation to sequence analysis.
    Sherefa K; Sönnerborg A; Steinbergs J; Sällberg M
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1658-64. PubMed ID: 7811250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E.
    Wasi C; Herring B; Raktham S; Vanichseni S; Mastro TD; Young NL; Rübsamen-Waigmann H; von Briesen H; Kalish ML; Luo CC
    AIDS; 1995 Aug; 9(8):843-9. PubMed ID: 7576317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotyping HIV-1 with V3 peptides: detection of high avidity antibodies presenting clade-specific reactivity.
    Casseb J; Katzenstein D; Winters M; Brigido LF; Duarte AJ; Hendry RM
    Braz J Med Biol Res; 2002 Mar; 35(3):369-75. PubMed ID: 11887216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. WHO Network for HIV Isolation and Characterization.
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1327-43. PubMed ID: 7545977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa.
    van Harmelen J; Wood R; Lambrick M; Rybicki EP; Williamson AL; Williamson C
    AIDS; 1997 Jan; 11(1):81-7. PubMed ID: 9110079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular subtypes of env sequences around V3 region of human immunodeficiency virus type 1 in Taiwan.
    Chang KS; Lin CI; Ling P; Lin KH; Lin HC; Twu SJ
    Eur J Epidemiol; 1994 Jun; 10(3):247-50. PubMed ID: 7859833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.
    Sherefa K; Sällberg M; Sönnerborg A
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1551-6. PubMed ID: 7534097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved algorithm for determining HIV type 1 subtypes in a primary laboratory in Uganda.
    Kaleebu P; Yirrell D; French N; Lyagoba F; Rutebemberwa A; Cheingsong-Popov R; Gilks C; Biryahwaho B; Weber J; Whitworth J
    AIDS Res Hum Retroviruses; 2000 May; 16(7):621-5. PubMed ID: 10791872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV type 1 V3 serotyping of Tanzanian samples: probable reasons for mismatching with genetic subtyping.
    Hoelscher M; Hanker S; Barin F; Cheingsong-Popov R; Dietrich U; Jordan-Harder B; Olaleye D; Nägele E; Markuzzi A; Mwakagile D; Minja F; Weber J; Gürtler L; Von Sonnenburg F
    AIDS Res Hum Retroviruses; 1998 Jan; 14(2):139-49. PubMed ID: 9462924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.